Cargando…

Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups

The primary objective of this study was to explore whether coronavirus disease 2019 (COVID-19) severity and outcomes varied between different ABO blood groups. This retrospective study included 363 COVID-19 confirmed patients who had their blood group recorded in the hospital medical records, from M...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokhary, Diyaa H, Bokhary, Nidal H, Seadawi, Lamees E, Moafa, Ahlam M, Khairallah, Hashim H, Bakhsh, Abdullah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896246/
https://www.ncbi.nlm.nih.gov/pubmed/35291516
http://dx.doi.org/10.7759/cureus.21838
_version_ 1784663120754507776
author Bokhary, Diyaa H
Bokhary, Nidal H
Seadawi, Lamees E
Moafa, Ahlam M
Khairallah, Hashim H
Bakhsh, Abdullah A
author_facet Bokhary, Diyaa H
Bokhary, Nidal H
Seadawi, Lamees E
Moafa, Ahlam M
Khairallah, Hashim H
Bakhsh, Abdullah A
author_sort Bokhary, Diyaa H
collection PubMed
description The primary objective of this study was to explore whether coronavirus disease 2019 (COVID-19) severity and outcomes varied between different ABO blood groups. This retrospective study included 363 COVID-19 confirmed patients who had their blood group recorded in the hospital medical records, from March to June 2020. Data representing demographics, clinical features, vital signs, laboratory findings, and COVID-19 outcomes were collected. Multivariate logistic regression was used for analysis and the results were adjusted for sociodemographic, clinical, and laboratory variables. The patients’ mean age was 50 ± 17.8 years. Of the 363 patients, 30% were blood group A, 22.3% were blood group B, 8.8% were blood group AB, and 38.8% were blood group O. Bivariate analysis showed that patients with blood group AB were more likely to be free of any medical disease (65.6%) compared to other blood groups (p = 0.007). Fever was the most common presenting complaint (66.7%), and it did not significantly vary with changes in ABO blood groups (p = 0.230). Regarding laboratory characteristics, only C-reactive protein (CRP) levels were significantly associated with the blood groups, with high levels seen in blood groups A, B, and O (p = 0.036). In multivariate analysis, variations in emergency department (ED) disposition, requirement of intensive care unit care, and requirement of mechanical ventilation were not statistically significant among the different ABO blood groups. Furthermore, no correlation was found between hospital death and the different ABO blood groups. In conclusion, COVID-19 is most prevalent among patients with blood group O and least prevalent among those with blood group AB. No particular blood group had worse COVID-19 disease severity and outcomes than other blood groups. Therefore, we believe that ABO blood grouping should not be used as a major assessment tool for COVID-19 disease severity and outcome, and other known risk factors should be investigated.
format Online
Article
Text
id pubmed-8896246
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88962462022-03-14 Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups Bokhary, Diyaa H Bokhary, Nidal H Seadawi, Lamees E Moafa, Ahlam M Khairallah, Hashim H Bakhsh, Abdullah A Cureus Emergency Medicine The primary objective of this study was to explore whether coronavirus disease 2019 (COVID-19) severity and outcomes varied between different ABO blood groups. This retrospective study included 363 COVID-19 confirmed patients who had their blood group recorded in the hospital medical records, from March to June 2020. Data representing demographics, clinical features, vital signs, laboratory findings, and COVID-19 outcomes were collected. Multivariate logistic regression was used for analysis and the results were adjusted for sociodemographic, clinical, and laboratory variables. The patients’ mean age was 50 ± 17.8 years. Of the 363 patients, 30% were blood group A, 22.3% were blood group B, 8.8% were blood group AB, and 38.8% were blood group O. Bivariate analysis showed that patients with blood group AB were more likely to be free of any medical disease (65.6%) compared to other blood groups (p = 0.007). Fever was the most common presenting complaint (66.7%), and it did not significantly vary with changes in ABO blood groups (p = 0.230). Regarding laboratory characteristics, only C-reactive protein (CRP) levels were significantly associated with the blood groups, with high levels seen in blood groups A, B, and O (p = 0.036). In multivariate analysis, variations in emergency department (ED) disposition, requirement of intensive care unit care, and requirement of mechanical ventilation were not statistically significant among the different ABO blood groups. Furthermore, no correlation was found between hospital death and the different ABO blood groups. In conclusion, COVID-19 is most prevalent among patients with blood group O and least prevalent among those with blood group AB. No particular blood group had worse COVID-19 disease severity and outcomes than other blood groups. Therefore, we believe that ABO blood grouping should not be used as a major assessment tool for COVID-19 disease severity and outcome, and other known risk factors should be investigated. Cureus 2022-02-02 /pmc/articles/PMC8896246/ /pubmed/35291516 http://dx.doi.org/10.7759/cureus.21838 Text en Copyright © 2022, Bokhary et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Bokhary, Diyaa H
Bokhary, Nidal H
Seadawi, Lamees E
Moafa, Ahlam M
Khairallah, Hashim H
Bakhsh, Abdullah A
Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups
title Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups
title_full Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups
title_fullStr Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups
title_full_unstemmed Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups
title_short Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups
title_sort variation in covid-19 disease severity and clinical outcomes between different abo blood groups
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896246/
https://www.ncbi.nlm.nih.gov/pubmed/35291516
http://dx.doi.org/10.7759/cureus.21838
work_keys_str_mv AT bokharydiyaah variationincovid19diseaseseverityandclinicaloutcomesbetweendifferentabobloodgroups
AT bokharynidalh variationincovid19diseaseseverityandclinicaloutcomesbetweendifferentabobloodgroups
AT seadawilameese variationincovid19diseaseseverityandclinicaloutcomesbetweendifferentabobloodgroups
AT moafaahlamm variationincovid19diseaseseverityandclinicaloutcomesbetweendifferentabobloodgroups
AT khairallahhashimh variationincovid19diseaseseverityandclinicaloutcomesbetweendifferentabobloodgroups
AT bakhshabdullaha variationincovid19diseaseseverityandclinicaloutcomesbetweendifferentabobloodgroups